RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$4.05
+0.08 (+2.02%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-15.80%
YTD
-3.57%
Open$4.00
Previous Close$3.97
Day High$4.16
Day Low$3.90
52W High$7.18
52W Low$2.77
Volume—
Avg Volume16.27M
Market Cap1.96B
P/E Ratio—
EPS$-1.04
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.31
Below
SMA 200
$4.89
Below
RSI (14)
34.7
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
13 analysts
Price Target
+613.6% upside
Current
$4.05
$4.05
Target
$28.90
$28.90
$21.05
$28.90 avg
$39.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 92.54M | 75.05M | 309.68M |
| Net Income | -798,983,942 | -583,199,957 | -18,426,824 |
| Profit Margin | -863.4% | -820.2% | -6.0% |
| EBITDA | -752,852,461 | -580,056,640 | -21,116,374 |
| Free Cash Flow | — | — | -13,211,156 |
| Rev Growth | +23.3% | +23.3% | +0.8% |
| Debt/Equity | 0.02 | 0.02 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |